Atria Investments Inc Sells 1,360 Shares of Elevance Health, Inc. $ELV

Atria Investments Inc reduced its holdings in Elevance Health, Inc. (NYSE:ELV) by 7.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 17,313 shares of the company’s stock after selling 1,360 shares during the period. Atria Investments Inc’s holdings in Elevance Health were worth $6,069,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Murphy Middleton Hinkle & Parker Inc. acquired a new stake in shares of Elevance Health during the 4th quarter worth approximately $5,941,000. Evergreen Wealth Management LLC grew its holdings in shares of Elevance Health by 33.5% during the 3rd quarter. Evergreen Wealth Management LLC now owns 17,283 shares of the company’s stock worth $5,584,000 after purchasing an additional 4,336 shares in the last quarter. Blume Capital Management Inc. grew its holdings in shares of Elevance Health by 236.7% during the 3rd quarter. Blume Capital Management Inc. now owns 6,145 shares of the company’s stock worth $1,986,000 after purchasing an additional 4,320 shares in the last quarter. Victory Capital Management Inc. boosted its stake in Elevance Health by 31.1% in the 3rd quarter. Victory Capital Management Inc. now owns 461,693 shares of the company’s stock valued at $149,182,000 after buying an additional 109,462 shares in the last quarter. Finally, Caprock Group LLC acquired a new stake in Elevance Health in the 3rd quarter valued at $1,638,000. 89.24% of the stock is owned by institutional investors.

Analyst Ratings Changes

ELV has been the topic of several recent analyst reports. Wells Fargo & Company decreased their price target on Elevance Health from $424.00 to $391.00 and set an “overweight” rating on the stock in a research note on Friday, January 30th. UBS Group set a $400.00 price target on Elevance Health in a research note on Thursday, January 29th. Barclays boosted their price target on Elevance Health from $393.00 to $408.00 and gave the company an “overweight” rating in a research note on Friday, April 24th. Guggenheim boosted their price target on Elevance Health from $396.00 to $399.00 and gave the company a “buy” rating in a research note on Friday, April 24th. Finally, The Goldman Sachs Group boosted their price target on Elevance Health from $350.00 to $370.00 and gave the company a “neutral” rating in a research note on Friday, April 24th. Thirteen investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $384.58.

Elevance Health Price Performance

Elevance Health stock opened at $392.74 on Friday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.48 and a current ratio of 1.48. The firm has a market cap of $85.29 billion, a P/E ratio of 16.71, a P/E/G ratio of 2.26 and a beta of 0.66. The business’s fifty day moving average is $322.88 and its two-hundred day moving average is $334.02. Elevance Health, Inc. has a 52 week low of $273.71 and a 52 week high of $412.96.

Elevance Health (NYSE:ELV) last posted its quarterly earnings data on Wednesday, April 22nd. The company reported $12.58 EPS for the quarter, topping analysts’ consensus estimates of $10.74 by $1.84. The company had revenue of $49.49 billion for the quarter, compared to analyst estimates of $48.21 billion. Elevance Health had a return on equity of 15.58% and a net margin of 2.62%.The business’s revenue was up 1.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $11.97 earnings per share. Elevance Health has set its FY 2026 guidance at 19.850- EPS. Equities research analysts forecast that Elevance Health, Inc. will post 26.79 earnings per share for the current fiscal year.

Elevance Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Wednesday, June 10th will be given a dividend of $1.72 per share. The ex-dividend date is Wednesday, June 10th. This represents a $6.88 dividend on an annualized basis and a dividend yield of 1.8%. Elevance Health’s payout ratio is presently 29.26%.

Elevance Health Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.